Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 01-2016 | 10-2015 | 07-2015 | 04-2015 | 01-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,981 | 4,369 | 5,161 | 6,080 | 7,810 |
| Marketable Securities | 2,150 | 2,400 | 2,400 | 2,400 | 2,650 |
| Receivables | N/A | N/A | N/A | N/A | 45 |
| TOTAL | $6,187 | $6,896 | $7,755 | $8,523 | $10,571 |
| Non-Current Assets | |||||
| PPE Net | 146 | 44 | 47 | 51 | 59 |
| Intangibles | 2,315 | 2,396 | 2,478 | 2,559 | 2,640 |
| TOTAL | $2,461 | $2,440 | $2,525 | $2,610 | $2,699 |
| Total Assets | $8,647 | $9,336 | $10,279 | $11,133 | $13,270 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,244 | 594 | 712 | 689 | 1,667 |
| TOTAL | $1,244 | $594 | $712 | $689 | $1,667 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,812 | 3,688 | 3,570 | 3,454 | 3,346 |
| TOTAL | $3,812 | $3,688 | $3,570 | $3,454 | $3,346 |
| Total Liabilities | $5,056 | $4,282 | $4,282 | $4,143 | $5,013 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,731 | 8,725 | 8,721 | 8,757 | 8,789 |
| Common Shares | 87 | 87 | 87 | 2,189 | 2,197 |
| Retained earnings | -147,742 | -146,149 | -144,856 | -143,254 | -141,018 |
| Other shareholders' equity | 14 | 14 | 14 | 350 | 350 |
| TOTAL | $3,591 | $5,054 | $5,998 | $6,990 | $8,258 |
| Total Liabilities And Equity | $8,647 | $9,336 | $10,279 | $11,133 | $13,270 |